|
POLR3F expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.07200001600683E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.162200E-02 |
| Stage1-vs-Stage3 |
1.129150E-01 |
| Stage1-vs-Stage4 |
5.61259999999342E-05 |
| Stage2-vs-Stage3 |
4.702300E-03 |
| Stage2-vs-Stage4 |
2.17679999999776E-05 |
| Stage3-vs-Stage4 |
9.402400E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.64760485441707E-11 |
| Normal-vs-Asian |
1.11022302462516E-16 |
| Caucasian-vs-AfricanAmerican |
9.837000E-01 |
| Caucasian-vs-Asian |
6.821800E-01 |
| AfricanAmerican-vs-Asian |
7.932800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.891200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.81412999999964E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.951800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.570600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.224800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.896000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.105800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.890000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.2505000000026E-05 |
| Classical-VS-Follicular |
6.704800E-03 |
| Classical-VS-Other |
4.280600E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
1.21250000040263E-07 |
| Tall-VS-Other |
3.160600E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.456820E-01 |
| Follicular-VS-Normal |
5.12845321765099E-12 |
| Other-VS-Normal |
1.65345999999511E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
2.241500E-03 |
|
|
